• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 3. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 4. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

Introduction to 2-Fluoro-5-methoxy-4-methylbenzoic acid (CAS No. 870221-15-1)

2-Fluoro-5-methoxy-4-methylbenzoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 870221-15-1, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This benzoic acid derivative features a unique structural motif, combining a fluoro substituent at the 2-position with methoxy and methyl groups at the 5- and 4-positions, respectively. Such a structural configuration imparts distinct electronic and steric properties, making it a valuable scaffold for the development of novel bioactive molecules.

The compound’s significance lies in its potential applications across various domains, particularly in the synthesis of pharmacologically relevant molecules. The presence of the fluoro atom, a well-documented modulator of metabolic stability and binding affinity, enhances its utility in drug design. Specifically, fluorine substitution can influence the lipophilicity and metabolic pathways of drug candidates, often leading to improved pharmacokinetic profiles. This characteristic has made 2-fluoro-5-methoxy-4-methylbenzoic acid a subject of interest for medicinal chemists seeking to optimize lead compounds.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting various therapeutic areas, including oncology, inflammation, and neurodegenerative diseases. The structural framework of 2-fluoro-5-methoxy-4-methylbenzoic acid provides a versatile platform for generating derivatives with enhanced binding affinity and selectivity. For instance, studies have demonstrated its utility in designing molecules that interact with enzyme active sites or receptor binding pockets. The methoxy and methyl groups contribute to fine-tuning the compound’s physicochemical properties, such as solubility and molecular interactions, which are critical for drug efficacy.

One notable application of 2-fluoro-5-methoxy-4-methylbenzoic acid is in the synthesis of kinase inhibitors. Kinases are pivotal enzymes involved in numerous cellular signaling pathways, and their dysregulation is often associated with diseases such as cancer. By incorporating this benzoic acid derivative into drug candidates, researchers aim to develop selective kinase modulators that can modulate disease pathways without significant off-target effects. Preliminary studies have shown promising results in vitro, indicating that derivatives of this compound exhibit inhibitory activity against specific kinases while maintaining good metabolic stability.

The role of fluorine-containing compounds in medicinal chemistry cannot be overstated. The introduction of fluorine at the 2-position of the benzoic acid core in 2-fluoro-5-methoxy-4-methylbenzoic acid enhances its interaction with biological targets due to its ability to modulate hydrogen bonding networks and electronic distributions. This property has been leveraged in the development of antiviral agents, where fluorinated benzoic acids have shown enhanced resistance to degradation by enzymatic processes. Furthermore, the methoxy group at the 5-position introduces additional hydrogen bonding potential, further refining the compound’s binding characteristics.

Recent advances in computational chemistry have accelerated the process of designing novel bioactive molecules based on frameworks like 2-fluoro-5-methoxy-4-methylbenzoic acid. Molecular modeling techniques allow researchers to predict how modifications at specific positions will affect binding affinity and selectivity. For example, virtual screening campaigns have identified promising derivatives that exhibit potent activity against target proteins while minimizing interactions with off-target sites. Such computational approaches are indispensable in modern drug discovery pipelines.

The synthetic accessibility of 2-fluoro-5-methoxy-4-methylbenzoic acid is another factor contributing to its appeal in pharmaceutical research. The compound can be synthesized through well-established organic reactions, such as Friedel-Crafts alkylation followed by halogenation and functional group transformations. This synthetic robustness ensures that researchers can efficiently generate libraries of derivatives for screening purposes. Additionally, the scalability of these synthetic routes allows for large-scale production when needed for preclinical or clinical studies.

In conclusion,2-fluoro-5-methoxy-4-methylbenzoic acid (CAS No.870221-15-1) represents a compelling scaffold for medicinal chemistry applications due to its unique structural features and versatile reactivity. Its potential as a building block for drug discovery is underscored by ongoing research into its derivatives across multiple therapeutic areas. As computational methods continue to refine molecular design processes,2-fluoro-5-methoxy-4-methylbenzoic acid is poised to play an increasingly significant role in the development of next-generation therapeutics.

• 1179609-46-1(2-fluoro-4-(2-methoxyphenyl)benzoic Acid)
• 1179926-83-0(2-fluoro-5-(5-fluoro-2-methoxyphenyl)benzoic Acid)
• 367-83-9(2-Fluoro-5-methoxybenzoic acid)
• 137654-21-8(2-Fluoro-6-methoxybenzoic acid)
• 870221-14-0(2-Fluoro-5-hydroxy-4-methylbenzoic acid)
• 1183080-90-1(2-fluoro-4-(4-methoxy-3-methylphenyl)benzoic Acid)
• 1183891-33-9(5-(2,5-dimethoxyphenyl)-2-fluorobenzoic acid)
• 1427418-53-8(6-fluoro-3-methoxy-2-methylbenzoic acid)
• 1184077-24-4(4-(2,5-dimethoxyphenyl)-2-fluorobenzoic acid)
• 877383-80-7(2-fluoro-4-(5-fluoro-2-methoxyphenyl)benzoic Acid)